Compare Chemfab Alka. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -201.97% of over the last 5 years
Flat results in Jun 26
Risky - Negative Operating Profits
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 538 Cr (Micro Cap)
NA (Loss Making)
43
0.67%
0.30
-0.91%
1.38
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-02-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd Technical Momentum Shifts Amid Bearish Trends
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a modest day gain of 0.59%, the stock continues to face significant headwinds as reflected in its technical indicators and relative performance against the broader market.
Read full news article
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Chemfab Alkalis Ltd Faces Bearish Momentum Amid Technical Downgrade
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade to a Strong Sell rating reflects deteriorating price action and weakening market sentiment amid broader sector challenges.
Read full news article Announcements 
Chemfab Alkalis Limited - Other General Purpose
04-Nov-2019 | Source : NSEChemfab Alkalis Limited has informed the Exchange that Disclosure of Related Party Transactions pursuant to Regulation 23(9) of Securities
Chemfab Alkalis Limited - Outcome of Board Meeting
31-Oct-2019 | Source : NSEChemfab Alkalis Limited has informed the Exchange regarding Board meeting held on October 30, 2019.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 02 Sep 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.04%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.7%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is -2.17% vs 9.74% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 1,093.75% vs 110.79% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -6.98% vs 2.16% in Mar 2025
YoY Growth in year ended Mar 2026 is 50.58% vs -126.37% in Mar 2025






